$1.52 0.02 (+1.32%)
11/25/2009 3:59 PM

DUSA Pharmaceuticals, Inc. (DUSA)

CAPS Rating: No stars

A dermatology company, which is engaged in the development and marketing Levulan photodynamic therapy and other products for common skin conditions.

Featured Broker Partners